Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Honestly, it makes the whole process easierI feel more balanced, less hungry, and Im not fighting cravings as much
Retatrutide has developed one of the most rapidly growing pre-clinical research profiles of any metabolic peptide currently in active study: Pre-clinical metabolic research in obese animal models has reported body weight and fat mass reductions with Retatrutide that exceed those observed with dual-receptor compounds including Tirzepatide at comparable doses and suggesting that the addition of glucagon receptor engagement to combined GLP-1/GIP agonism produces meaningfully greater metabolic effects in experimental settings
Female participants at the 12mg dose achieved an average weight loss of 25.3 percent at 48 weeks
Despite their overall safety profile, older adults taking GLP-1s who have frailty or a history of heart attack or stroke may need additional clinical support to ensure that they are meeting their nutritional needs and getting sufficient physical activity to mitigate reductions in muscle mass and function
